News and Press Releases

Calluna Pharma appoints Margrethe Sørgaard as Senior Vice President of Clinical Operations and Pharmacovigilance

First senior executive appointment made following Company launch to oversee strategic development of clinical programmes 23 April 2024 -- Oslo, Norway -- Calluna Pharma, a clinical stage company pioneering a...

Category: Other, Pharmaceutical
Posted: April 23, 2024

Nytt Foretak AS, Grundingen 6, 0250 Oslo, Norway.

G.ST Antivirals reports start of Phase 2 trial and announces appointment of Ronald Bruce Turner as new Chief Medical Officer

Phase 2 clinical trial started, first subject in on 2 April 2024 New CMO Ronald Bruce Turner MD, distinguished expert in the clinical research of rhinoviruses, to oversee trial and...

Category: Biotechnology, Clinical Trials
Posted: April 9, 2024

Dr. Bohr-Gasse 7 (VBC6) 1030 Vienna Austria

Bio-Rad Launches First Ultrasensitive Multiplexed Digital PCR Assay for Breast Cancer Mutation Detection in Clinical Research

Highly Sensitive and Multiplexed Assay for the Detection, Discrimination and Quantification of Key Mutations in ESR1 Gene for Breast Cancer, Developed for Bio-Rad’s QX600 Droplet Digital PCR System 2 April...

Category: Clinical Trials
Posted: April 2, 2024

Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET

One2Treat launches ground-breaking treatment-decision approach to clinical research and market access analysis

One2Treat reflects patient priorities in a single comprehensive treatment evaluation, reducing trial sample size and accelerating patient access to new treatments 26 March 2024 -- Brussels, Belgium -- One2Treat, a...

Category: Clinical Trials, Pharmaceutical
Posted: March 26, 2024

Rue Emile Francqui, 1-1435 Mont-Saint-Guibert, Belgium

Kindeva Drug Delivery Welcomes Jennifer Riter, New Vice President of Analytical Services

18 March 2024 -- Minnesota, US, and Missouri, US -- Kindeva Drug Delivery, a global leader in drug-device combination products, today welcomes Jennifer Riter as vice president of Analytical Services to...

Category: Drug Delivery
Posted: March 18, 2024

Faller Packaging announces long-term appointment of new chief executive officer

Dr Michael Faller and Dr Daniel Keesman will step down for reasons of age in the second half of 2024. Dagmar Schmidt will become the new CEO 13 March 2024...

Category: Manufacturing and Packing
Posted: March 13, 2024

Freiburger Strasse 25 D-79183 Waldkirch

Veramed appoints Karen Curran as Chief Strategy Officer

12 March 2024 -- LONDON, UK -- Specialist Biometrics CRO, Veramed, today announced the appointment of Karen Curran as chief strategy officer at Veramed. Karen joins during a period of...

Category: Other
Posted: March 12, 2024

5th Floor Regal House, 70 London Road, Twickenham, TW1 3QS, UK

Clinigen boosts senior team with three strategic hires 

12 March 2024 -- London, UK -- Clinigen, the global pharmaceutical services company, today announces three strategic appointments to advance its transformation into a world leading pharma services company: Nihad...

Category: Other
Posted: March 12, 2024

25 Bedford Square Bloomsbury London WC1B 3HH

WCG Expands New Statistical Consulting Solutions to Address Industry Resource Challenges

4 March 2024 -- New Jersey, US -- WCG, the global leader in providing solutions that measurably improve and accelerate clinical research, announces the expansion of its capabilities with the...

Category: Clinical Trials
Posted: March 4, 2024

212 Carnegie Center, Suite 301, Princeton, NJ 08540, USA

Sequani invests in industry leading facilities as it eyes future growth

26 February 2024 -- Ledbury, UK -- As part of their strategic plans for growth and to meet the evolving needs of modern product developers, Ledbury-based contract research organisation (CRO)...

Category: Drug Discovery
Posted: February 27, 2024

Bromyard Road, Ledbury HR8 1LH United Kingdom

First MYC inhibitor to demonstrate safety and anti-tumour activity in a phase 1 first-in-human clinical trial

Developed in-house by VHIO-born spin-off company Peptomyc, OMO-103 is a mini-protein targeting the MYC oncogene which is found deregulated in most, if not all tumor types. Until recently, MYC has...

Category: Drug Discovery
Posted: February 7, 2024

C/ Natzaret, 115-117 Barcelona, Spain, 08035

AES Clean Technology enhances cleanroom construction capabilities through new senior appointment

1 February 2024 -- Pennsylvania, US -- A leading provider of high-performance cleanroom facilities, AES Clean Technology, has announced the appointment of John Costalas to its senior leadership team as...

Category: Manufacturing and Packing
Posted: February 1, 2024

422 Stump Road, Montgomeryville, PA 18936

Cellular Origins, a TTP Company, appoints Peter Crossley as Chief Operating Officer

Product and technology innovator will build team to further develop and deliver Cellular Origins’ products for cell and gene therapy manufacture at scale 25 January 2024 -- Cambridge, UK --...

Category: BioManufacturing
Posted: January 25, 2024

TTP Campus Cambridge Road Melbourn SG8 6HQ

Leading biometrics CRO Phastar to share vast statistical expertise with biotechs working to build the drugs of the future

23 January 2024 -- London, UK and North Carolina, US -- Phastar, a global specialist biometrics contract research organisation (CRO), has announced the launch of Stats Helpdesk, a new initiative...

Category: Biotechnology
Posted: January 23, 2024

Unit 2, 2A Bollo Ln, Chiswick, London W4 5LE

AES Clean Technology expands senior leadership team with key appointment

18 January 2024 -- Pennsylvania, US -- A leading provider of high-performance cleanroom facilities, AES Clean Technology, has appointed Brian Weed as chief revenue officer (CRO). With 18 years of...

Category: Manufacturing and Packing
Posted: January 18, 2024

422 Stump Road, Montgomeryville, PA 18936